`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner
`
`v.
`
`ALCON RESEARCH, LTD
`Patent Owner
`__________________
`
`Patent No. 8,791,154
`Issue Date: July 29, 2014
`Title: HIGH CONCENTRATION OLOPATADINE
`OPHTHALMIC COMPOSITION
`__________________
`
`Inter Partes Review No. 2016-00544
`__________________
`
`
`PATENT OWNER’S MANDATORY NOTICES
`
`37 C.F.R. 42.8(a)(2)
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), the Patent Owner submits the following
`
`mandatory notices:
`
`(1) Real parties-in-interest.
`
`Alcon Research, Ltd. is a corporation organized and existing under the laws
`
`of the State of Delaware and has a principal place of business at 6201 South
`
`Freeway, Fort Worth, Texas 76134. Alcon is the assignee of U.S. Patent No.
`
`8,791,154 (the “’154 patent”).
`
`Alcon Research, Ltd. is a wholly-owned subsidiary of Novartis AG, a
`
`corporation organized and existing under the laws of Switzerland, having an office
`
`and place of business at Lichtstrasse 35, CH-4056 Basel, Switzerland.
`
`(2) Related matters.
`
`The following matters, in which the ’154 patent has been asserted, could
`
`affect, or could be affected by, a decision in this proceeding:
`
`• Alcon Research, Ltd. v. Watson Laboratories, Inc., Actavis Pharma,
`Inc., and Actavis Inc., Civil Action No. 15-1159-SLR (D. Del.).
`
`(3) Lead and back-up counsel.
`
`The Patent Owners designate the following lead and back-up counsel:
`
`
`
`Lead Counsel:
`
`David M. Krinsky
`
`Reg. No. 72,339
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5338 (Telephone)
`
`
`
`
`
`
`
`
`
`
`
`Back-up Counsel:
`Thomas S. Fletcher
`Reg. No. 72,383
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5497 (Telephone)
`
`
`
`
`
`
`
`
`
`2
`
`
`
`
`
`
`
`202-434-5029 (Facsimile)
`dkrinsky@wc.com
`
`
`
`
`
`
`
`
`
`202-434-5029 (Facsimile)
`tfletcher@wc.com
`
`Powers of attorney appointing these attorneys to transact all business in this
`
`proceeding are submitted together with this mandatory notice information.
`
`(4) Service information.
`
`Counsel for Patent Owner submits the following service information:
`
`
`(i)
`
`Electronic mail address:
`
`dkrinsky@wc.com
`tfletcher@wc.com
`pazeo-IPR@wc.com
`
`David M. Krinsky
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington D.C. 20005
`
`
`(ii) Postal mailing address:
`
`
`
`(iii) Hand-delivery address: David M. Krinsky
`Williams & Connolly LLP
` 725 Twelfth Street, N.W.
` Washington D.C. 20005
`
`
`
`
`202-434-5338
`
`(iv) Telephone number:
`
`Facsimile number:
`
`Counsel for Patent Owner consent to electronic service by email at
`
`(v)
`
`
`
`202-434-5029
`
`dkrinsky@wc.com, tfletcher@wc.com, and pazeo-IPR@wc.com.
`
`
`Dated: February 22, 2016
`
`
`Respectfully submitted,
`
`
`
` /David M. Krinsky/
`
`David M. Krinsky
`
`
`
`
`
`3
`
`
`
`Reg. No. 72,339
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5338 (Telephone)
`202-434-5029 (Facsimile)
`dkrinsky@wc.com
`
`
`
`4
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing Mandatory Notice
`Information Pursuant to 37 C.F.R. § 42.8(a)(2) through the Patent Review
`Processing System as well as by delivering a copy via electronic mail on the
`following attorneys of record for the petitioner:
`
`
`Michael R. Houston, Ph.D. (Reg. No. 58,486)
`Joseph P. Meara, Ph.D. (Reg. No. 44,932)
`Foley & Lardner LLP, 3000 K St. N.W., Suite 600
`Washington, D.C. 20008
`jmeara-PGP@foley.com
`
`
`
`5